Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint
NCT ID: NCT01394042
Last Updated: 2011-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
12 participants
INTERVENTIONAL
2011-06-30
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer
NCT01359189
Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study
NCT02786459
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147
Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer
NCT02079025
A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values
NCT01553838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No intervention
All consenting patients will be imaged with the Proxiscan and data compared with MRI, ProstaScint and biopsy data
Proxiscan device
All patients will be imaged with the device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proxiscan device
All patients will be imaged with the device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Transrectal ultrasound (TRUS)-guided prostate biopsy within 6 months of study enrollment
* Sufficient time period to complete imaging protocol and 5-7 day safety followup assessment without other therapeutic intervention
* In the judgement of principal investigator, patient able to provide informed consent and be compliant with protocol requirements
* ECOG status of 0 or 1 Pt \> 18 yrs of age
Exclusion Criteria
* Prior pelvic therapeutic radiation
* Active malignancy or therapy for malignancy with 6 months other than basal or squamous cell carcinoma of the skin
* Pt received radiopharmaceutical which was within 5 half-lives at the time of studying imaging
* Known history of human-anti-murine-antibodies or known allergic reaction to previously received murine based products
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hybridyne Imaging Technologies
UNKNOWN
Radiological Associates of Sacramento Medical Group Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
RAS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin Franc, MD
Role: PRINCIPAL_INVESTIGATOR
Radiological Associates of Sacramento Medical Group Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roseville PET and Nuclear Imaging Center
Roseville, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Proxiscan
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.